Please check your internet connection and try again.
# Diloxanide furoate
## Overview
Diloxanide furoate is an amebicide used to treat intestinal amebiasis. It is thought to act by disrupting protein synthesis in *Entamoeba histolytica*.
## Primary Indications
* Asymptomatic intestinal amebiasis (luminal amebicide).
* Used in conjunction with a tissue amebicide for invasive amebiasis.
## Adult Dosing
* **Asymptomatic intestinal amebiasis:** 500 mg orally three times daily for 10 days.
## Pediatric Dosing
* **Asymptomatic intestinal amebiasis:** 20 mg/kg/day orally divided into three doses, for 10 days. Maximum daily dose is 1.5 g/day. Specific dosing may depend on local pediatric guidelines and product availability.
## Dose Adjustments
No specific dose adjustments are recommended for renal or hepatic impairment, as systemic absorption is minimal.
## Contraindications
* Known hypersensitivity to diloxanide furoate.
## Adverse Effects
The most common adverse effects are gastrointestinal, including nausea, vomiting, abdominal cramps, and diarrhea. Itching and urticaria have also been reported.
## Key Drug Interactions
No significant drug interactions have been widely reported.
## Monitoring
* Resolution of symptoms.
* Stool examination for amebae may be considered following treatment, especially in cases of invasive disease.
## Clinical Pearls
* Diloxanide furoate is primarily effective against the luminal trophozoites and cysts of *Entamoeba histolytica* and is